---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-016746"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2023-05-12T23:59:59+00:00"
generated_at: "2026-06-15T02:39:10.707354+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions posts Q3 net loss $6.34M on $457K rev; goodwill impairment $4.1M

## Summary
- Combined revenue & govt support $574,738 (+199% YoY); product revenue $457,058 from Intelligent Fingerprinting acquisition.
- Net loss $6.34M ($5.72 per share) vs $1.34M ($1.79) prior year; includes $4.1M non-cash goodwill impairment.
- Filed 513(g) FDA submission for drug screening cartridge; granted UK patent for DSR-Plus Cartridge Reader (13th patent).
- Completed biosensor Milestone 7: 4x improvement in time-to-result (<1 min); advancing to human saliva testing.
- Cash and equivalents $2.3M as of March 31, 2023; new sales team and distribution hub established in Australia.

## SEC filing metadata
- accession: 0001493152-23-016746
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2023-05-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016746/0001493152-23-016746-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016746/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-016746
- JSON: https://secwatch.observer/filing/0001493152-23-016746.json
- Plain text: https://secwatch.observer/filing/0001493152-23-016746.txt

## Key facts
- Earnings Releases
  INTELLIGENT BIO SOLUTIONS INC. reported fiscal third quarter ended March 31, 2023 results: revenue $457,058, net income $6.34 million, EPS $5.72 per share.
  - Period: fiscal third quarter ended March 31, 2023
  - Revenue: $457,058
  - Net income: $6.34 million
  - EPS: $5.72 per share
  - Result: reported results
  source text: The Company’s combined revenue and government support income increased by 199% or $382,238 to $574,738 for the three months ending March 31, 2023, including revenue of $457,058, compared to the same period in 2022. The year-over-year revenue increase reflects the acquisition of Intelligent Fingerprinting Ltd. during the fiscal 2023 second quarter and the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315223016746/0001493152-23-016746-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.